MedPath

ALBERT EINSTEIN HEALTHCARE NETWORK

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website
http://www.einstein.edu/

Mycophenolate Mofetil Immunosuppression Without/With Reduced Dose Calcineurin Inhibitor Long After Liver Transplantation

Phase 4
Completed
Conditions
Liver Disease
Interventions
First Posted Date
2005-09-21
Last Posted Date
2013-08-02
Lead Sponsor
Albert Einstein Healthcare Network
Target Recruit Count
19
Registration Number
NCT00206076
Locations
🇺🇸

University of Kentucky at Lexington, Lexington, Kentucky, United States

🇺🇸

Albert Einstein Medical Center, Philadelphia, Pennsylvania, United States

🇺🇸

Texas Transplant Institute, San Antonio, Texas, United States

© Copyright 2025. All Rights Reserved by MedPath